Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$143.95 3.41 (2.31%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 17.71(B)
Last Volume: 477,045 Avg Vol: 726,924
52 Week Range: $143.71 - $212.05
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 46,855 76,855 102,504 247,093
Total Sell Value $7,107,715 $12,957,715 $17,713,340 $48,829,179
Total People Sold 6 7 8 9
Total Sell Transactions 11 12 18 35
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 475
  Page 6 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Maraganore John Chief Executive Officer   •       •      –    2021-04-20 4 D $131.75 $989,822 D/D (7,507) 214,765     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-04-19 4 AS $136.76 $510,192 D/D (3,706) 19,202 47%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-04-19 4 A $0.00 $0 D/D 5,083 22,908     -
   Poulton Jeffrey V. Chief Financial Officer   •       –      –    2021-04-19 4 A $0.00 $0 D/D 4,518 4,518     -
   Greenstreet Yvonne President & COO   •       –      –    2021-04-19 4 A $0.00 $0 D/D 5,083 13,374     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-04-19 4 A $0.00 $0 D/D 4,518 8,955     -
   Maraganore John Chief Executive Officer   •       •      –    2021-04-19 4 A $0.00 $0 D/D 16,236 222,272     -
   Maraganore John Chief Executive Officer   •       •      –    2021-02-25 4 AS $143.88 $5,005,421 D/D (33,979) 206,036 18%     
   Maraganore John Chief Executive Officer   •       •      –    2021-02-25 4 OE $7.10 $241,251 D/D 33,979 240,015     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-02-12 4 D $152.53 $266,441 D/D (1,710) 17,825     -
   Greenstreet Yvonne President & COO   •       –      –    2021-02-12 4 D $155.84 $303,403 D/D (1,945) 8,291     -
   Maraganore John Chief Executive Officer   •       •      –    2021-02-12 4 D $151.94 $890,917 D/D (5,719) 206,036     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-02-12 4 D $153.54 $305,967 D/D (1,963) 4,437     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-02-11 4 A $0.00 $0 D/D 5,416 19,535     -
   Greenstreet Yvonne President & COO   •       –      –    2021-02-11 4 A $0.00 $0 D/D 5,416 10,236     -
   Maraganore John Chief Executive Officer   •       •      –    2021-02-11 4 A $0.00 $0 D/D 14,166 211,755     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-02-11 4 A $0.00 $0 D/D 4,166 6,400     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-01-13 4 AS $169.00 $1,533,698 D/D (9,027) 2,234 -18%     
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-01-13 4 OE $77.40 $744,290 D/D 9,027 11,261     -
   Greenstreet Yvonne President & COO   •       –      –    2021-01-12 4 AS $161.00 $503,125 D/D (3,125) 4,820 -15%     
   Greenstreet Yvonne President & COO   •       –      –    2021-01-12 4 OE $42.22 $131,938 D/D 3,125 7,945     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-01-12 4 AS $159.00 $2,393,619 D/D (14,941) 2,234 -15%     
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-01-12 4 OE $42.22 $1,088,149 D/D 14,941 17,175     -
   Keating Laurie EVP, Chief Legal Officer   •       –      –    2021-01-11 4 AS $154.00 $116,732 D/D (758) 2,234 -11%     
   Paul Steven M Director   –       •      –    2020-12-18 4 AS $140.00 $2,100,000 D/D (15,000) 1,000 -1%     
  475 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us